A batch of drugs were found to be involved in ViC silver warp tablets, a gum...

On August 10, the Jiangsu Provincial Drug Administration issued the "Notice on the Quality of Drugs No. 2 of 2020" (hereinafter referred to as the "Notice").
, according to the annual sampling work plan of the Jiangsu Provincial Drug Administration, the bureau organized sampling of drug production, operation and use units.
in the sampling found that 14 batches of drugs did not meet the requirements.
It is worth noting that in this batch of drugs, there are three preparations, namely chloramphenicillin tablets, vitamin C silver warp tablets, cypress heart-raising tablets;
notice pointed out that for non-compliant drugs, Jiangsu Province drug supervision and administration departments at all levels have asked relevant enterprises and units to take suspension of sales, use and other risk control measures, the reasons for non-compliance to carry out investigations and effective rectification.
drug supervision and administration departments at all levels in Jiangsu Province have organized and carried out investigation and punishment of relevant enterprises and units in accordance with the law.
: 1 batch of drugs suspended from sale, recall August 7, the Guangdong Provincial Drug Administration issued "2020 No. 4 drug spot check inspection information notice" (hereinafter referred to as "spot check notice").
in order to strengthen drug quality supervision and ensure the safety of drug use by the public, the Guangdong Provincial Drug Administration has organized drug quality spot checks and tests on pharmaceutical production, operating enterprises and medical institutions throughout the province, according to the 2020 Guangdong Provincial Drug Sampling Plan.
the province recently tested a total of 43 pharmaceutical production enterprises, 184 pharmaceutical enterprises and 6 medical institutions of 287 varieties of a total of 608 batches of drugs.
After verification and confirmation, the current period of sampling information published as follows: 287 varieties 607 batches of tested in accordance with the provisions of drug standards, 1 variety of 1 batch after testing does not meet the requirements of drug standards, mainly do not meet the requirements of heavy metals and harmful elements.
The notice shows that the Guangdong Provincial Drug Administration has tasked the relevant municipal market supervision bureau to take the necessary control measures such as seizure, seizure, suspension of sales and recall of non-conforming drugs, to investigate and punish the production enterprises and sampled units in accordance with relevant laws and regulations, and to continue to follow up spot checks and tests on these drugs.
At the same time, the Guangdong Provincial Drug Administration reminded that consumers in legal formal medical institutions, pharmacies, etc. to buy drugs and request the preservation of relevant documents;
If necessary, you may visit the basic database of the State Drug Administration (CFDA) website to check the relevant information on drug registration, and after purchasing the drug, you should store the drug according to the storage conditions indicated in the instruction manual, and take the drug according to medical instructions or usage, paying special attention to the adverse reactions, taboos, precautions and so on.
.